| Display title | Chemistry:Chiral switch |
| Default sort key | Chiral switch |
| Page length (in bytes) | 26,258 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 554607 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>OrgMain |
| Date of page creation | 21:53, 5 February 2024 |
| Latest editor | imported>OrgMain |
| Date of latest edit | 21:53, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | A chiral switch is a chiral drug that has already approved as racemate but has been re-developed as a single enantiomer. The term chiral switching was introduced by Agranat and Caner in 1999 to describe the development of single enantiomers from racemate drugs. For example, levofloxacin is a chiral... |
